Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients-Reference-Cited by-同舟云学术

Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients

Published:2022-10-24 Issue:11 Volume:15 Page:1317-1326
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Crutcher Madison M.¹,Snook Adam E.²³^ORCID,Waldman Scott A.²

Affiliation:

1. Department of Surgery, Thomas Jefferson University, Philadelphia, PA, USA

2. Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, USA

3. Department of Microbiology & Immunology, Thomas Jefferson University, Philadelphia, PA, USA

Funder

National Institutes of Health

Defense Congressionally Directed Medical Research Program

West Pharmaceutical Services, Inc

The Courtney Ann Diacont Memorial

Lorraine and David Swoyer

NIH institutional award

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2022.2138339

Reference82 articles.

1. Global colorectal cancer burden in 2020 and projections to 2040

2. Cancer statistics, 2022

3. Surveillance, Epidemiology, and End Results Program. [Internet]. [cited 2022 Mar 14]. Available from: https://seer.cancer.gov/.

4. Amin MB. American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. 8th ed. Chicago IL: Springer; 2016: 1049. 2017, Corr. 3rd printing 2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AEG-1 as a Novel Therapeutic Target in Colon Cancer: A Study from Silencing AEG-1 in BALB/c Mice to Large Data Analysis;Current Gene Therapy;2024-08